Alexander V Bocharov Selected Research

Fibrosis (Cirrhosis)

9/2015

TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander V Bocharov Research Topics

Disease

7	Inflammation (Inflammations) 09/2023 - 08/2004
3	Acute Lung Injury 10/2022 - 01/2016
3	Sepsis (Septicemia) 01/2021 - 03/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2016
2	Pneumonia (Pneumonitis) 09/2023 - 01/2023
2	Lung Injury 09/2023 - 01/2023
2	Infections 07/2023 - 03/2012
2	Bacterial Infections (Bacterial Infection) 01/2021 - 03/2012
1	Overweight 10/2023
1	Endotoxemia 01/2021
1	Carcinogenesis 11/2017
1	Neoplasms (Cancer) 11/2017
1	Virus Diseases (Viral Diseases) 11/2017
1	Chronic Renal Insufficiency 04/2016
1	Pulmonary Edema 01/2016
1	Fibrosis (Cirrhosis) 09/2015
1	Albuminuria 09/2015
1	Atherosclerosis 01/2015
1	Brain Diseases (Brain Disorder) 09/2011
1	Parkinson Disease (Parkinson's Disease) 09/2011
1	Hyperlipidemias (Hyperlipidemia) 05/2010
1	Pathologic Processes 03/2010
1	Septic Shock (Toxic Shock Syndrome) 06/2003
1	Tangier Disease 04/2003

Drug/Important Bio-Agent (IBA)

4	Scavenger Receptors (Scavenger Receptor)IBA 01/2021 - 03/2012
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2023 - 04/2003
3	Peptides (Polypeptides)IBA 09/2023 - 01/2016
3	LipidsIBA 07/2023 - 04/2003
3	EndotoxinsIBA 01/2021 - 09/2015
3	LipopolysaccharidesIBA 04/2016 - 06/2003
2	1- palmitoyl- 2- (5- keto- 6- octenedioyl)phosphatidylcholineIBA 01/2024 - 01/2023
2	Lipoproteins (Lipoprotein)IBA 10/2023 - 01/2015
2	1-penicillamyl-Leu(2)- oxytocinIBA 09/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 09/2023 - 07/2023
2	CholesterolIBA 07/2023 - 01/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023 - 06/2003
2	Class B Scavenger ReceptorsIBA 10/2022 - 01/2021
1	Apolipoproteins B (ApoB)IBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023
1	Evans Blue (Blue, Evans)FDA Link 09/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2023
1	SU 6656IBA 09/2023
1	Nystatin (Mycostatin)FDA LinkGeneric 07/2023
1	OxysterolsIBA 07/2023
1	Angiotensin-Converting Enzyme 2IBA 07/2023
1	Dihydrotachysterol (AT 10)IBA 07/2023
1	25-hydroxycholesterolIBA 07/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2023
1	CyclodextrinsIBA 07/2023
1	GW 3965IBA 07/2023
1	VimentinIBA 07/2023
1	AntibodiesIBA 07/2023
1	Small Interfering RNA (siRNA)IBA 07/2023
1	Dynamin IIBA 07/2023
1	Dynamins (Dynamin)IBA 07/2023
1	Lovastatin (Mevacor)FDA LinkGeneric 07/2023
1	We 201IBA 01/2023
1	GlucocorticoidsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2017
1	Programmed Cell Death 1 ReceptorIBA 09/2015
1	InflammasomesIBA 09/2015
1	CreatinineIBA 09/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2015
1	Angiotensin IIIBA 09/2015
1	Toll-Like Receptor 4IBA 09/2015
1	HDL CholesterolIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	CytokinesIBA 03/2012
1	SynucleinsIBA 09/2011
1	APOBEC-1 DeaminaseIBA 05/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2010
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2010
1	ApolipoproteinsIBA 08/2004
1	paraform (paraformaldehyde)IBA 04/2003

Therapy/Procedure

1	Therapeutics 10/2023
1	Nephrectomy 09/2015
1	Punctures 03/2012
1	Ligation 03/2012